The use of targeted radionuclide therapy for the treatment of malignant melanoma in vivo

Joyce, C. and Boyd, M. and Sorensen, A. and Tesson, M. and Babich, J. W. and Mairs, R. J. (2012) The use of targeted radionuclide therapy for the treatment of malignant melanoma in vivo. Mutagenesis, 27 (1). p. 110. ISSN 0267-8357 (https://doi.org/10.1093/mutage/ger068)

Full text not available in this repository.Request a copy

Abstract

This study investigates the potential of the noradrenaline analogue [131I]MIBG (metaiodobenzylguanidine) and the novel melanin binding benzamide [131I] Solazed for melanoma therapy in vivo and in vitro.

ORCID iDs

Joyce, C., Boyd, M. ORCID logoORCID: https://orcid.org/0000-0003-4120-2218, Sorensen, A. ORCID logoORCID: https://orcid.org/0000-0002-1861-7258, Tesson, M., Babich, J. W. and Mairs, R. J.;